Medicare Enrolled

Dr. Pierre Gholam, MD

Gastroenterology · Cleveland, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
11100 EUCLID AVE, Cleveland, OH 44106
2168448500
In practice since 2006 (20 years)
NPI: 1477579647 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gholam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gholam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gholam

Dr. Pierre Gholam is a gastroenterology specialist in Cleveland, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gholam performed 175 Medicare services across 115 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gholam received a total of $1,388,333 from 36 pharmaceutical and/or device companies across 1754 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gholam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 175 Medicare services $1,388,333 industry payments

Medicare Practice Summary

Medicare Utilization ↗
175
Medicare services
Bottom 16% in OH for gastroenterology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
115
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
82 $92 $214
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
32 $65 $158
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $76 $158
Liver stiffness measurement
A non-invasive test that uses ultrasound or similar technology to measure the stiffness of liver tissue. This measurement helps assess the degree of liver fibrosis or scarring.
19 $8 $37
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $43 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,388,333
Total received (2018-2024)
Avg $198,333/year across 7 years
Top 0% in OH for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
1,754
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,250,767 (90.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$97,952 (7.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$39,614 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$231,797
2023
$216,803
2022
$177,412
2021
$133,255
2020
$112,816
2019
$267,766
2018
$248,485

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Ipsen Biopharmaceuticals, Inc
$74,130
Eisai Inc.
$38,737
Gilead Sciences, Inc.
$31,690
Madrigal Pharmaceuticals
$25,905
ABBVIE INC.
$20,002
Intercept Pharmaceuticals, Inc.
$15,486
Exelixis Inc.
$11,502
AstraZeneca Pharmaceuticals LP
$8,014
Novo Nordisk Inc
$3,314
Genentech USA, Inc.
$2,873
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$98
Ardelyx, Inc.
$17
Mirum Pharmaceuticals, Inc.
$16
Genentech, Inc.
$14
Top 3 companies account for 62.4% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$197,474
Eisai Inc.
$182,018
Exelixis Inc.
$172,035
AbbVie, Inc.
$155,266
EISAI INC.
$89,318
ABBVIE INC.
$78,938
AstraZeneca Pharmaceuticals LP
$77,259
Intercept Pharmaceuticals, Inc.
$76,015
Ipsen Biopharmaceuticals, Inc
$74,130
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$42,096
Bayer HealthCare Pharmaceuticals Inc.
$36,952
AbbVie Inc.
$33,549
INTERCEPT PHARMACEUTICALS, INC.
$27,666
Madrigal Pharmaceuticals
$25,905
Shionogi Inc
$25,359
Dova Pharmaceuticals
$17,514
Alnylam Pharmaceuticals Inc.
$13,948
Genentech USA, Inc.
$12,488
Merck Sharp & Dohme Corporation
$12,381
E.R. Squibb & Sons, L.L.C.
$10,713
Synergy Pharmaceuticals Inc
$8,810
Novo Nordisk Inc
$7,955
F. Hoffmann-La Roche AG
$7,260
Genentech, Inc.
$2,389
BeiGene, Ltd.
$350
Janssen Biotech, Inc.
$119
Eiger BioPharmaceuticals, Inc.
$104
Mallinckrodt Hospital Products Inc.
$73
Shire North American Group Inc
$69
IRONWOOD PHARMACEUTICALS, INC
$36
Ironwood Pharmaceuticals, Inc
$33
Takeda Pharmaceuticals U.S.A., Inc.
$31
Allergan Inc.
$30
PFIZER INC.
$18
Ardelyx, Inc.
$17
Mirum Pharmaceuticals, Inc.
$16
Top 3 companies account for 39.7% of all-time payments
Associated products mentioned in payments ›
Avastin · CABOMETYX · Cabometyx · DALVANCE · Doptelet · Entyvio · Epclusa · FASENRA · GATTEX · GIVLARRI · HUMIRA · Halaven · Humira · IBSRELA · IMFINZI · INFLECTRA · IQIRVO · KEYTRUDA · LINZESS · LYNPARZA · Lenvima · Linzess · Livdelzi · Livmarli · MAVYRET · Mavyret · Mulpleta · Nexavar · OCALIVA · OPDIVO · RELISTOR · RESMETIROM · REZDIFFRA · RINVOQ · STELARA · Stivarga · TECENTRIQ · TERLIVAZ · TRULANCE · Tecentriq · Trulance · VIBERZI · Vemlidy · XIFAXAN · XIFAXANIBSD · ZEPATIER · ZOKINVY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for gastroenterology in OH.

Looking for a gastroenterology specialist in Cleveland?
Compare gastroenterologists in the Cleveland area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
134
Per 100K population
10.7
County median income
$62,823
Nearest hospital
LOUIS STOKES CLEVELAND VA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gholam is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gholam experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Gholam performed 82 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gholam receive payments from pharmaceutical companies?
Yes. Dr. Gholam received a total of $1,388,333 from 36 companies across 1,754 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gholam's costs compare to other gastroenterologists in Cleveland?
Dr. Gholam's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gholam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →